Alere Inc. Receives Grant and Loan From Gates Foundation to Develop Low-Cost TB and HIV Diagnostic Tests
Massachusetts-headquartered Alere Inc. announced on March 1 that it was awarded by the Bill & Melinda Gates Foundation more than $20 million in grant money and debt financing of up to $20.6 million for the development of an inexpensive TB test and HIV test.
In a news release, Alere said the $21.6 million grant will be used to produce a tuberculosis assay for both resource-constrained and well-resourced settings. The fund will also support the company’s efforts to incorporate one of its isothermal amplification technologies for TB detection onto the Alere™ Q — a compact, portable, and robust device intended for molecular testing at the point of care.
Alere will also receive below-market loans of up to $20.6 million for the expansion of the company’s manufacturing facilities in Jena, Germany for both point-of-care TB tests and HIV tests. Gates Foundation’s only condition is to make the diagnostic tests affordable and available to people in need in developing countries.
“Providing affordable products that transform the way medicine is practiced, especially in resource-limited settings, is part of Alere’s heritage,” Alere CEO Ron Zwanziger said. “We are very excited to have the support of the Gates Foundation in fighting one of the most dangerous infectious diseases, and we remain committed to providing solutions that improve health outcomes for individuals living with HIV.”
For over a decade, Alere has been developing and providing solutions that support screening for the world’s worst diseases, such as TB and HIV. Its new product development efforts focus on cardiology, infectious disease, toxicology and diabetes.
“Alere has a track record of diagnostic innovation and leveraging cost-effective technologies to improve health outcomes for individuals living with HIV in the most remote parts of the world. The Gates Foundation has put its support behind the company to apply these same principles in addressing the TB epidemic and potentially saving millions of lives,” said Bill Gates, co-chair of the Bill & Melinda Gates Foundation.

The survey indicated further that 9 percent of intravenous drug users were infected by the human immunodeficiency virus (HIV), the virus that causes AIDS.
Hospital officials have denied the children could have been infected by its blood supplies while State Health Minister Jay Narayan Vyas said that it is possible that the children might have been infected from getting blood transfusions at some other place.
Experts believe, however, that this should not be the case. A
A study conducted by Harvard has determined that South Africa saw more than 300,000 premature deaths related to AIDS which were entirely preventable had the appropriate medication been administered to AIDS patients as well as to pregnant women in order to prevent the passing on of the HIV virus to their respective children. During the administration of the country’s former President, Thabo Mbeki, there were doubts regarding the link between HIV and AIDS. The regime’s health minister also did not trust life-extending drugs developed for AIDS patients and promoted beets and garlic as treatment for AIDS.
The decline is also being attributed to the fact that more people are
Many people worry about contracting HIV, the virus that leads to AIDS. Even today, there is somewhat of a stigma with this disease that can be caught through blood or body fluid transmission. Many people are afraid to take a test to see if they have the disease. They do not want to go to the doctor for such a test because they are afraid of the doctor passing judgment against them. This can be especially true if the person lives in a small community and knows their family doctor very well.

